Lento Bio was formed in 2022 in partnership with Ichor Life Sciences, with the goal to develop effective, safe, and durable treatments for chronic age-related disease by using small molecules to directly target molecular damage.
| Website | http://lentobio.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2022 |
| Address | 831 James St, Syracuse, New York 13203, US |
| Industry | Biotechnology Research |
| Keywords | Aging Research, Small Molecule Therapeutics, Geroscience, Age Related Diseases, Cellular Senescence, Chronic Disease Treatment, Life Extension, Healthspan, Anti-Aging Therapies, Molecular Medicine, Drug Discovery, Pharmaceutical Research, Therapeutic Development, Regenerative Medicine, Biotechnology, Innovative Treatments, Drug Development, Clinical Trials |
Looking for a particular Lento Bio employee's phone or email?
Kris Barnes is the CEO of Lento Bio.
1 people are employed at Lento Bio.
Lento Bio is based in Syracuse, New York.